Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Clarus Therapeutics (CRXT)

Clarus Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRXT
DateTimeSourceHeadlineSymbolCompany
07/03/202311:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202312:36Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202312:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202312:20Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202312:17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202312:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
22/02/202321:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
24/01/202321:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
22/12/202221:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
23/11/202211:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
18/10/202221:05GlobeNewswire Inc.Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful BidderNASDAQ:CRXTClarus Therapeutics Holdings Inc
14/09/202214:52Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CRXTClarus Therapeutics Holdings Inc
06/09/202203:19GlobeNewswire Inc.Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy CodeNASDAQ:CRXTClarus Therapeutics Holdings Inc
26/08/202221:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
26/08/202221:33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
26/08/202221:30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
26/08/202221:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
22/08/202217:05TipRanksClarus Therapeutics Holdings (CRXT) was downgraded to a Hold Rating at NeedhamNASDAQ:CRXTClarus Therapeutics Holdings Inc
19/08/202211:38Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
19/08/202211:34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
19/08/202211:32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
19/08/202211:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRXTClarus Therapeutics Holdings Inc
18/08/202221:50Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
18/08/202221:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
18/08/202221:05GlobeNewswire Inc.Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce ReductionNASDAQ:CRXTClarus Therapeutics Holdings Inc
10/08/202211:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
10/08/202211:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
09/08/202222:25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
28/07/202214:05GlobeNewswire Inc.Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)NASDAQ:CRXTClarus Therapeutics Holdings Inc
06/07/202221:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRXTClarus Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CRXT

Your Recent History